Test Price
1,600 AED✅ Home Collection Available
Prenatal Diagnostic Screening by Karyotyping in UAE | 1600 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- ✔ Diagnostic Sensitivity: 99.9% — ISO 9001:2015 Accredited Cell Culture & G‑Banding (400–550 Bands)
- ✔ Clinical Guidance: Telephonic Post‑Test Interpretation with a DHA‑Licensed Consultant Medical Geneticist
- ✔ Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- ✔ Insurance: Direct Billing Verification — Send your policy copy on WhatsApp +971 54 548 8731
Test Overview & Methodology
Prenatal Diagnostic Screening by Karyotyping is the gold‑standard invasive test that analyses the complete chromosomal set of a fetus using cultured amniotic fluid or chorionic villus cells. This technique provides definitive diagnosis of chromosomal aneuploidies including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13) with greater than 99.9% sensitivity. The karyotype is essential for pregnancies with advanced maternal age, abnormal ultrasound markers, or a positive non‑invasive screening result.
| Feature | Our Test (Karyotyping) | Closest Alternative (NIPT Screening) |
|---|---|---|
| Precision | Diagnostic, >99.9% sensitivity | Screening only; requires confirmation |
| Methodology | Cell culture + G‑banding (400–550 bands) | Cell‑free DNA NGS |
| Turnaround Time | 15–20 working days | 5–7 days |
| Sample Required | Amniotic fluid or chorionic villus tissue | Maternal blood (non‑invasive) |
Physician Insight & Safety Protocols
“Prenatal karyotyping provides a definitive chromosomal blueprint that empowers families and clinicians to make informed decisions. Every result must be interpreted within the full clinical context of the pregnancy. Our laboratory combines rigorous cytogenetic methodology with compassionate post‑test counselling to support you throughout this journey.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Guidance
⚠️ Clinical Advisory:
Always continue all prescribed medications unless your treating obstetrician explicitly advises otherwise. Do not alter or stop any therapy based on test results without direct consultation.
Exclusion Criteria & ER Red Flags
Contraindications and Emergency Signs
- Contraindications for Sample Collection: Active vaginal bleeding, chorioamnionitis, severe oligohydramnios, or placental location over the sampling site.
- Emergency Warning Signs (post‑procedure): Heavy vaginal bleeding, fever >38°C, fluid leakage, severe abdominal pain, or reduced fetal movements. Seek immediate hospital attention.
- Prescription Requirement: A valid prescription from a DHA‑licensed obstetrician/gynecologist is mandatory in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is prenatal karyotyping and why is it done?
Prenatal karyotyping maps all 46 chromosomes from fetal cells to diagnose Down syndrome, trisomy 18, and other aneuploidies. It is indicated for advanced maternal age, abnormal ultrasound markers, or a positive screening result. The analysis provides definitive genetic information to guide pregnancy management and parental counselling.
2. How is the sample collected for karyotyping?
A specialist collects amniotic fluid via amniocentesis or chorionic villus tissue under continuous ultrasound guidance to ensure fetal safety. Both procedures are performed by an experienced obstetrician in a sterile hospital environment. You may resume normal activities after a brief observation period of one to two hours.
3. How long does it take to get results from prenatal karyotyping?
Results are available in 15 to 20 working days after cell culture initiation and chromosomal analysis. This timeline includes rigorous quality checks and a two‑stage reporting process. An interim verbal update can be arranged when clinically urgent.
4. What conditions can prenatal karyotyping detect?
Karyotyping detects numerical chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome aneuploidies. It can also identify structural rearrangements including translocations and large deletions that may affect fetal development.
5. Is prenatal karyotyping covered by health insurance in the UAE?
Coverage varies by insurance provider and policy. DNA Labs UAE offers direct billing verification — send your policy copy via WhatsApp at +971 54 548 8731 for a pre‑authorisation check. Many comprehensive plans include diagnostic genetic testing when ordered by a DHA‑licensed obstetrician.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All processes adhere to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genomic information is encrypted and stored on DHA‑authorised servers. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Support & Booking Enquiries: WhatsApp +971 54 548 8731 | Direct Line: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | Prenatal Diagnostic Screening by Karyotyping |
| Price (AED) | 1,600 AED |
| Turnaround Time | 15–20 Working Days |
| Sample Type / Matrix | Amniotic Fluid or Chorionic Villus Tissue |
| Methodology Used | Cell Culture & G‑Banding (400–550 Bands) |
| ICD-10-CM Code | Z36.2 |
| LOINC Code | 38285-2 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians